Abstract
On the background of the well-known age-dependent structural and functional changes of different body organs, our data show that age is a significant risk indicator in cardiac surgery, strongly correlating with morbidity and mortality. Consequently, special preventive and therapeutic measures are required in the clinical environment for elderly patients undergoing cardiac surgery.
Introduction
As medical technology advances and global demographics shift, the proportion of elderly patients undergoing cardiac surgery has increased dramatically. In Germany alone, the number of patients aged 70 and older tripled between 1989 and 2000. To manage the risks associated with this population, clinicians rely on tools like the EuroSCORE, which treats age as an independent risk factor, assigning additional points for every five-year increment over the age of 60.
However, a critical question persists: Is chronological age itself the driver of mortality, or is it a proxy for the accumulation of comorbidities—a "cluster" of diseases like renal failure, lung disease, and heart tissue degradation? This study investigates whether age remains an independent predictor when non-age-related sickness levels are accounted for.
Methods
This retrospective study analyzed 8,769 patients who underwent cardiac surgery at the Heart Institute Lahr/Baden between 1996 and 2002. The researchers utilized a comprehensive institutional database that integrated records from anesthesiology, clinical laboratories, and national quality control databases.
To isolate the impact of age, the team compared two metrics:
- Standard EuroSCORE: The traditional risk calculation.
- Age-Adjusted (Age-Stripped) EuroSCORE: A modified version where points specifically assigned for age were removed.
Patients were categorized into seven age groups (ranging from <60 to 90 years). Statistical analyses, including ANOVA, Pearson’s Chi-square, and stepwise logistic regression, were employed to identify the strongest predictors of 30-day mortality and postoperative complications.
Key Findings
The study found a clear correlation between advancing age and adverse outcomes across several dimensions:
- Mortality Trends: 30-day mortality rates rose from 0.7% in the youngest group (<60) to 5.2% in the oldest group (86–90).
- Morbidity Spikes: Postoperative complications showed even sharper increases. Most notably, the incidence of postoperative confusion jumped from 2.0% in the youngest cohort to 24.1% in the oldest.
- Sickness Levels: Both standard and age-stripped EuroSCOREs increased significantly with age (p < 0.005), confirming that older patients are objectively "sicker" across nearly all measured variables.
- Predictors: Logistic regression identified diabetes as a particularly potent independent predictor of mortality that becomes increasingly prevalent with age.
Discussion: The "Dead Patient" Paradox
One of the most significant findings was observed in the cohort of patients who did not survive the 30-day postoperative period. In this group, the age-stripped EuroSCORE did not change significantly across age groups. This suggests that for patients who die, the severity of their non-age-related comorbidities is the primary driver of mortality, regardless of their chronological age.
The authors argue that age in the EuroSCORE acts as a "catch-all" for factors the model fails to capture explicitly, such as the duration and intensity of chronic diseases (e.g., long-term COPD) and diastolic heart dysfunction. Age is not just a single risk factor but a gateway to a "multimorbidity cluster" including hypertension and atrial fibrillation.
Conclusion
While age is a powerful indicator of risk in cardiac surgery, its role as an "independent" determinant is complex. It likely masks underlying structural organ decline and specific comorbidities not always captured in standard assessments. As the surgical population ages, moving beyond chronological age to incorporate markers of biological frailty and specific organ function will be essential for more accurate risk stratification and the development of targeted preventive measures.
Summary updated